Long-term follow-up after native valve -, prosthetic valve - and cardiovascular implanted electronic device related – infective endocarditis

Ralf Zahn (Ludwigshafen am Rhein)1, E. J. Taner (Ludwigshafen am Rhein)1, A.-K. Karcher (Ludwigshafen am Rhein)1, C. Kilkowski (Ludwigshafen am Rhein)1, R. Winkler (Ludwigshafen am Rhein)1, T. Kleemann (Ludwigshafen am Rhein)1, T. Ouarrak (Ludwigshafen am Rhein)2, S. Schneider (Ludwigshafen am Rhein)3, D. Sutor (Ludwigshafen am Rhein)1, U. Weiße (Ludwigshafen am Rhein)1, F.-U. Sack (Ludwigshafen am Rhein)4

1Klinikum der Stadt Ludwigshafen gGmbH Medizinische Klinik B Ludwigshafen am Rhein, Deutschland; 2Stiftung Institut für Herzinfarktforschung Ludwigshafen am Rhein, Deutschland; 3IHF GmbH Ludwigshafen am Rhein, Deutschland; 4Klinikum der Stadt Ludwigshafen gGmbH Ludwigshafen am Rhein, Deutschland

 

Background: Infective endocarditis (IE) is still a serious disease, with a high hospital and long-term mortality. However, data on differences between native valve (NV) IE, prosthetic valve (PV) IE and cardiovascular implanted electronic device (CIED) related IE are sparse.

Methods: Retrospective single centre registry on the hospital course and long-term follow-up of patients with IE.

Results: Between 1/2013 and 12/2016, 171 IE patients were treated at our hospital. A follow-up with either patient contact, review of hospital charts or physician contact was performed in 2022. Due to lost to follow-up (n=4) and refusal to participate after discharge (n=1), the final evaluation was performed with 166 patients (97,1%). They were followed-up for a median 2385,0 (between 2156,0 and 2773,0) days.

 

NV-IE

n=85

PV-IE

n=53

CIED-IE

n=33

 

p-value

Age (years)

63±14

70±13

70±13

0,01

Women

28,2%

20,8%

24,2%

ns

renal failure

21,2%

41,5%

48,5%

0,005

Positive blood cultures

78,8%

88,7%

69,7%

ns

Gram positive strains

97%

100%

96%

ns

In-hospital cardiac surgery

87,1%

67,9%

87,9%

0,01

Hospital mortality

23,5%

20,8%

18,2%

ns

Follow-up (after median 2385 days)

 

 

 

 

Calculated 1 year mortality

27,7%

32,0%

21,2%

ns

Calculated 3 year mortality

43,4%

44,0%

42,4%

ns

Calculated 5 year mortality

53,0%

58,0%

48,5%

ns

Endocarditis related mortality

 

 

 

 

Probable/certain

66,7%

62,9%

81,0%

 

Uncertain

11,8%

20,0%

4,8%

 

Not related

21,6%

17,1%

14,3%

 

Re-hospitalisation for recurrent IE

75,0%

76,0%

80,0%

ns

Conclusions: These data on long-term follow-up after IE show only little differences between NV-IE, PV-IE and CIED-IE, with NV-IE patients being younger and having less co-morbidities. Cardiac surgery was less often performed in PV-IE. However, long-term mortality is similar in all groups, with more than 2/3 of deaths were due to IE. Furthermore, rehospitalisation rates for recurrent IE were also high.

Diese Seite teilen